Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Nautilus eBook – Proteomics and cancer

Key Takeaway: The article discusses the role of proteomics in understanding cancer biology and developing precision medicine. It highlights recent findings from the Clinical Proteomic Tumor Analysis Consortium, emphasizing the potential of proteomics to identify cancer vulnerabilities. The eBook aims to showcase how these insights can lead to innovative diagnostics and therapeutics for cancer patients.
Price reaction · baseline $2.6445 (2023-11-02T15:40:00.000Z) · hit during market hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close · peak
+1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Proteomics is positioned to identify vulnerabilities in cancer.
  • Recent studies show promise in developing novel therapeutics.
  • Proteomics may lead to new cancer diagnostics and treatments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Applications of Proteomics
Tyler Ford
November 2, 2023

Generating a mechanistic understanding of cancer through proteomics

Genomics research has helped cement cancer’s roots as a genetic disease, enabled researchers to discover many cancer-driving mutations, and driven inspiring successes in the field of precision medicine
Nonetheless, many cancer patients still don’t have effective precision medicines or do not achieve durable responses (see Rodriguez et al. for an overview of successes and gaps in precision medicines for cancer). Given that proteins are the molecular machines that control most biological functions, and most drugs target proteins, it makes intuitive sense to look to the proteome to better understand the biology of cancer and find the appropriate pathways to drug in individual patients.
In this eBook, we distill results from a variety of recent proteomic investigations of cancer. These studies are often conducted through the Clinical Proteomic Tumor Analysis Consortium and are monumental efforts involving many skilled researchers. Their findings make it clear that proteomics is well-positioned to identify vulnerabilities in cancer and direct the development of novel therapeutics and diagnostics.
Watch this animation to learn how proteomics can drive cancer research:

Proteomics and cancer

Learn how proteomics is advancing cancer research and may usher in the creation of new cancer diagnostics and treatments.
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics applications in medicine, basic biology, and beyond
Proteomics is being applied in many biological fields to unlock new discoveries and drive scientific advances.
Read more
White paper series: The proteomics revolution
This post contains white papers describing how developments in proteomics - led by the Nautilus platform - will improve healthcare.
Read more
Targeting healthcare disparities through the proteomics revolution (Part 1)
Learn how biases have led to inequities in healthcare and how researchers can rectify those inequities with better data.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is the focus of the Nautilus eBook?

The eBook focuses on the applications of proteomics in understanding cancer and developing precision medicine.

How does proteomics contribute to cancer research?

Proteomics helps identify vulnerabilities in cancer, guiding the development of new therapeutics and diagnostics.

What consortium is mentioned in the article?

The Clinical Proteomic Tumor Analysis Consortium is highlighted for its significant contributions to cancer proteomics.

What advancements does the eBook discuss?

It discusses advancements in proteomics that may lead to innovative cancer diagnostics and treatments.

Last updated: Nov 2, 2023